top of page


ASCEND Cardiovascular Goes Live in the Cloud as the Cardiology Solution Within a Pacific Northwest Enterprise Transformation
Cloud-hosted, multi-modality structured reporting brings cardiology-specific depth to an enterprise-wide technology transformation. FOR IMMEDIATE RELEASE SPRINGFIELD, Ill. — October 8, 2026 — ASCEND Cardiovascular today announced that its cardiovascular reporting platform is now cloud-hosted and live within an enterprise cardiology environment in Vancouver, Wash. The go-live, which began September 28, 2026, was part of a healthcare organization's enterprise-wide technology tr
Oct 83 min read
ASCEND Cardiovascular and Epsilon Imaging Partner to Streamline Adult and Pediatric Advanced Echo Analysis, with Strain Imaging, and Reporting Workflows
Chicago, IL - August 4th, 2026] - ASCEND Cardiovascular, a leader in cardiovascular structured reporting and workflow solutions, and Epsilon Imaging, a leading provider of vendor-neutral advanced echocardiography analysis software, today announced a strategic non-exclusive partnership. The partnership is designed to deliver an integrated, "best-of-breed" solution for clinical echo analysis, reading and reporting. By natively connecting ASCEND’s enterprise structured reporting
Aug 113 min read
A Zero-Friction Echo Lab: How ASCEND and Epsilon Imaging Simplify Workflow and Expand Access to Strain Imaging
Speckle-tracking strain imaging, particularly Global Longitudinal Strain (GLS), has evolved from a research measure into a routine clinical necessity. Whether assessing subclinical cardiotoxicity in oncology, monitoring early heart failure, or evaluating complex valvular disease, myocardial deformation metrics provide insight into cardiac function that traditional Ejection Fraction (EF) cannot match. Even with strong clinical evidence and clear guideline support, many echocar
Jun 285 min read
VENTRIPOINT and ASCEND Cardiovascular sign Term Sheet for integration of VMS+ into ASCEND’s Gen3Echo™ platform
Toronto, Ontario – December 18, 2024 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce Ventripoint and ASCEND Cardiovascular, a leading provider of cardiovascular IT solutions, have signed a term sheet defining the general terms and conditions for a non-exclusive license to Ventripoint’s VMS+ proprietary technology. The two parties expect to execute the license agreement within 30 days. ASCEND Cardiovascular has ov
May 224 min read
Archives
bottom of page

